We are delighted to announce the grant of our first patent in low-pain ultrasonic needles. The technology opens a range of high-value applications in medical, healthcare and cosmetic markets.

Active Needle Technology Ltd. will continue to develop devices in these areas and looks forward to exciting developments in due course.

Previous
Previous

We are excited to announce that Active Needle Technology Ltd. has developed the world’s first ultrasonic tattoo device, Tranquill™, for medical and non-medical applications.

Next
Next

ActiveNeedle is honoured to have received additional funding from NC3Rs to commercialise our new, high precision injection system.